Cargando…

MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going

SIMPLE SUMMARY: The problem of drug resistance represents a major challenge for the cure of non-small cell lung cancer. Tumor cells can be intrinsically resistant to drugs or they can become resistant during the treatment as a result of several adaptive responses. However, molecular mechanisms at th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuttano, Roberto, Afanga, Miriam Kuku, Bianchi, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740066/ https://www.ncbi.nlm.nih.gov/pubmed/36497213 http://dx.doi.org/10.3390/cancers14235731

Ejemplares similares

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

Yellow fever control in Cameroon: Where are we now and where are we going?
por: Wiysonge, Charles Shey, et al.
Publicado: (2008)

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

Structure functions and the EMC effect: where are we now and where are we going to?
por: Wimpenny, S J
Publicado: (1984)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Reflection for the undergraduate on writing in the portfolio: where are we now and where are we going?
por: AHMED, MOHAMED H
Publicado: (2018)

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?
por: Gazerani, Parisa
Publicado: (2020)

Individualized Treatment Strategy for Cutaneous Melanoma: Where Are We Now and Where Are We Going?
por: Zeng, Huihua, et al.
Publicado: (2021)

A Comprehensive Review on Bariatric Endoscopy: Where We Are Now and Where We Are Going
por: Mauro, Aurelio, et al.
Publicado: (2023)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020)

Breast Implant Surfaces and Their Impact on Current Practices: Where We Are Now and Where Are We Going?
por: Munhoz, Alexandre Mendonça, et al.
Publicado: (2019)

Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?
por: Giri, Paresh C., et al.
Publicado: (2021)

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
por: Mesnier, Jules, et al.
Publicado: (2022)

A personal view on basic education in reproduction: Where are we now and where are we going?
por: Jonker, F. Herman
Publicado: (2020)

Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going
por: Mazzitelli, Carlotta, et al.
Publicado: (2023)

Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
por: Varrone, Francesca, et al.
Publicado: (2021)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Where are we now?
Publicado: (1977)

Moderate ischemic mitral regurgitation (IMR) and metabolic syndrome: where are we now and where are we going?
por: Osman, Khalid A, et al.
Publicado: (2006)

Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
por: Ramani, Sasirekha, et al.
Publicado: (2016)

Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?
por: Buttgereit, Frank, et al.
Publicado: (2015)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
por: Omarini, Claudia, et al.
Publicado: (2018)

Comment on: Breast Implant Surfaces and Their Impact on Current Practices: Where Are We Now and Where Are We Going
por: Nava, Maurizio Bruno, et al.
Publicado: (2020)

Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014)

A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
por: Griffin, Morag, et al.
Publicado: (2020)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ah025k2e07ns2qq9t0kouuiiih